Medizinische Universitätsklinik Bochum

www.medunikkh.de

AMLSG 21-13 Phase III Studie Randomized Phase III Study of Intensive Chemotherapy with or without Dasatinib ( Sprycel ) in Adult Patients with Newly Diagnosed Core-Binding Factor Acute Myeloid Leukemia ( CBF-AML)